Cbi Laboratories, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

396 documents for Cbi Laboratories, Inc.

- Commonwealth Biotechnologies, Inc. Enters Into Agreement to Sell the Assets of its CBI Services and Fairfax Identity Laboratories Divisions.
RICHMOND, Va. -- Commonwealth Biotechnologies, Inc. ("CBI") (NASDAQ Capital Market:CBTE) is pleased to announce that an agreement has been signed with...
- Business Wire
- July 21, 2009
- Certain New Chemicals; Receipt and Status Information
Section 5 of the Toxic Substances Control Act (TSCA) requires any person who intends to manufacture (defined by statute to include import) a new chemical (i.e., a chemical not on the TSCA Chemical Substances Inventory (TSCA Inventory)) to notify EPA and comply with the statutory provisions pertaining to the manufacture of new chemicals. Under TSCA sections 5(d)(2) and 5(d)(3), EPA is required to publish in the Federal Register a notice of receipt of a premanufacture notice (PMN) or an application for a test marketing exemption (TME), and to publish in the Federal Register periodic status reports on the new chemicals under review and the receipt of notices of commencement (NOC) to manufacture those chemicals. This document, which covers the period from November 1, 2011 to December 2, 201...

... Laboratories, Inc. substit...
- Federal Register Nbr. 77 FR 5092, February 01, 2012
- Notices
- Environmental Protection Agency
- Toxic and hazardous substances control: New chemicals; receipt and status information,
... to manufacture (defined by statute to include import) a new chemical (i.e., a chemical not on th...(G) Iodoalkyl Laboratories, Inc. intermediate -. substituted catechol destruc...
- FR, January 19, 2007
- Notices
- Environmental Protection Agency

- Decongel(R) Provides Radiological Decontamination Technology to Japan in Wake of Fukushima Daiichi Nuclear Power Plant Crisis
HONOLULU, April 11, 2011 /PRNewswire/ -- CBI Polymers LLC, the Honolulu-based innovator of DeconGel(R) nuclear decontaminant, will join the broad-based philanthropic effort to help with the crisis in Japan by making a donation of $250,000 in radiological decontamination products and technical services at the request of the Japanese Medical Association (JMA) for the removal of radioactive contaminants in support of public health and emergency relief efforts for the people in the Tohoku region, Japan's most severely-affected northeastern coast. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/cellular- bioengineering/46956/

...Ron Marotta of NYK Logistics Inc., which provided logistics support for DeconGel(R)..., hospital facilities and research laboratories. For more information, please visit the English la...
- U.S. Newswire
- April 11, 2011
- Commonwealth Biotechnologies, Inc. Announces New Contracts.
... from Prism and at other contract laboratories. . About Commonwealth Biotechnologies, Inc . The C...
- Business Wire
- June 21, 2007
- Thermotrex Corp.
... its 81 percent-owned subsidiary, ThremoLase Inc., the company is also developing a laser-based, lo...'s wholly owned subsidiary, CBI Laboratories Inc., acquired in 1993, the company manufactures s...
- San Diego Business Journal
- August 22, 1994
- Commonwealth Biotechnologies, Inc. Provides Market Update.
... of CBI Services and Fairfax Identity Laboratories divisions to Bostwick Laboratories (Business Wire,...
- Business Wire
- August 03, 2009
- Infocomm 2006 Exhibitor Profiles.
... around the globe, 360 Systems' brands include Digicart(R), Instant Replay(R), Short/cut(TM) Edit... and is an approved Underwriters Laboratories testing site. For more information, visit www.peer...
- Business Wire
- June 01, 2006
- Venturepharm Laboratories Becomes a Strategic Investor and Joint Venture Partner of Commonwealth Biotechnologies, Inc.
Joint Venture to Establish the First Fully Integrated, U.S.-China Based Pharmaceutical Contract Research Organization RICHMOND, Va. -- Commonwealth ...
- Business Wire
- April 01, 2008
- Revisions to the Unregulated Contaminant Monitoring Regulation (UCMR 3) for Public Water Systems
The 1996 amendments to the Safe Drinking Water Act (SDWA) require that the United States Environmental Protection Agency (EPA or the agency) establish criteria for a program to monitor unregulated contaminants and publish a list of up to 30 contaminants to be monitored every five years. This final rule meets the SDWA requirement by publishing the third Unregulated Contaminant Monitoring Regulation (i.e., UCMR 3), listing the unregulated contaminants to be monitored and addressing the requirements for such monitoring. This final rule describes analytical methods to monitor for 28 chemical contaminants and describes the monitoring for two viruses. UCMR 3 provides EPA and other interested parties with scientifically valid data on the occurrence of these contaminants in drinking water, perm...

...The incorporation by reference of certain publications listed in thi...-house and in cooperation with other laboratories. 2. Hormones and Related Methods. a. This Rule. ...
- Federal Register Nbr. 77 FR 26072, May 02, 2012
- Rules and Regulations
- Environmental Protection Agency